Urgent

Acute exacerbation of COPD (severe)

Type 2 risk · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

An acute COPD exacerbation is a sustained WORSENING of respiratory symptoms — increased DYSPNOEA, increased SPUTUM VOLUME, and increased SPUTUM PURULENCE (the three Anthonisen cardinal symptoms) — beyond normal day-to-day variation, needing a change in treatment. Most are triggered by respiratory infection (viral or bacterial) or air-pollutant exposure. The danger is progressive type 2 (hypercapnic) respiratory failure with a respiratory acidosis. Assessment is CLINICAL and physiological — there is no single confirmatory test — and the key early decision is whether the patient has a compensated flare or is heading for ventilatory failure.

Red flags

  • Rising PaCO₂ with a falling pH (worsening respiratory acidosis) despite therapy
  • Exhaustion, drowsiness/confusion (CO₂ narcosis), or a silent chest
  • Severe hypoxaemia, haemodynamic instability, or new arrhythmia
  • Failure to improve on controlled oxygen + nebulisers — escalate to NIV early

Assessment

Investigations

  • ARTERIAL BLOOD GAS is central — it defines type 1 vs type 2 failure and detects a respiratory ACIDOSIS (low pH, high PaCO₂) that drives the need for NIV
  • Chest X-ray — look for pneumonia, pneumothorax, effusion or pulmonary oedema (alternative/added diagnosis)
  • ECG and consider troponin/BNP (cardiac comorbidity, cor pulmonale, arrhythmia)
  • FBC, U&E, CRP; sputum culture if purulent/failing therapy; and always EXCLUDE PE and heart failure, which mimic and coexist with exacerbations

Complications & pitfalls

  • Type 2 respiratory failure and respiratory acidosis (may need NIV, then intubation)
  • Pneumonia, pneumothorax, pulmonary embolism
  • Cor pulmonale / right-heart failure and arrhythmias (e.g. AF, multifocal atrial tachycardia)
  • Oxygen-induced hypercapnia if uncontrolled high-flow O₂ is given to a CO₂ retainer

Exam pearls

  • The three cardinal (Anthonisen) symptoms — more breathlessness, more sputum, more purulent sputum — define the exacerbation and guide antibiotic use (antibiotics benefit most when sputum is purulent or the patient needs ventilatory support).
  • TITRATE oxygen to a target SpO₂ of 88–92% in patients at risk of hypercapnia (use a 24–28% Venturi / controlled device) — the goal is to correct hypoxaemia without abolishing respiratory drive.
  • Cornerstone drug therapy: nebulised SHORT-ACTING bronchodilators (salbutamol + ipratropium), SYSTEMIC CORTICOSTEROIDS (e.g. prednisolone 30–40 mg for ~5 days), and ANTIBIOTICS for infective (purulent) exacerbations.
  • Start NIV (bilevel) for a persistent respiratory acidosis (pH < 7.35 with PaCO₂ high) despite optimal medical therapy — it reduces intubation and mortality; escalate to intubation if NIV fails or is contraindicated.
  • Always look for a precipitant/mimic — pneumonia, pneumothorax, PE, heart failure, arrhythmia — and treat it.

Treat a severe COPD exacerbation with CONTROLLED oxygen to 88–92%, nebulised salbutamol + ipratropium, systemic corticosteroids (~5 days) and antibiotics for purulent/infective flares; do a blood gas early and start NIV for a persistent respiratory acidosis (pH < 7.35) — escalate to intubation if NIV fails. Exclude and treat mimics (pneumonia, PE, pneumothorax, heart failure).

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.